
Small Business Innovation Research
Description
The Small Business Innovation Research (SBIR) program is a highly significant, non-dilutive funding mechanism established by the U.S. federal government, designed to stimulate technological innovation among small businesses. It serves multiple objectives, including meeting federal research and development needs, fostering participation by small businesses in federally-funded R&D, and encouraging the commercialization of innovative technologies. Unlike traditional venture capital firms, SBIR provides grants or contracts rather than equity investments, making it an attractive option for early-stage companies seeking to de-risk their technology without relinquishing ownership.
The program operates through a competitive, three-phase structure. Phase I awards focus on establishing the scientific, technical, and commercial merit and feasibility of a proposed R&D effort, typically lasting 6-12 months. Successful Phase I projects can then apply for Phase II funding, which supports the principal R&D effort and aims to bring the technology closer to commercialization, usually over a 2-year period. Phase III involves the commercialization of the technology developed under Phases I and II, utilizing non-SBIR funds. Various federal agencies, including the Department of Defense, National Institutes of Health, and National Science Foundation, participate in the SBIR program, each with specific R&D needs and funding priorities.
Funding amounts vary considerably across the participating agencies and phases. For instance, federal agencies with an extramural R&D budget exceeding $100 million are mandated to set aside 3.2% of that budget for SBIR awards in fiscal year 2024. While Phase I awards generally range from $150,000 to $250,000, some agencies or specific solicitations may offer higher amounts, occasionally up to $1 million or more for specific topics or "Direct to Phase II" awards. Phase II awards are substantially larger, often ranging from $750,000 to $1.5 million, with some agencies providing awards exceeding $3 million, depending on the scope and agency. In fiscal year 2022 alone, the combined SBIR and STTR (Small Business Technology Transfer) programs awarded over $4 billion to small businesses across the nation, underscoring their critical role in the innovation ecosystem.
This program is a cornerstone for many deep tech and life science startups, providing crucial early-stage capital that often bridges the gap between academic research and private investment. Its non-dilutive nature allows founders to retain full equity while developing their technology, making it a powerful tool for small businesses to pursue high-risk, high-reward R&D that might otherwise struggle to attract conventional venture capital due to its early stage or specialized nature.
Investor Profile
Small Business Innovation Research has backed more than 133 startups, with 5 new investments in the last 12 months alone. The firm has led 99 rounds, about 74% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, India, Japan.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 4 rounds in the past year.
- Typical check size: $150K – $250K.
Stage Focus
- Grant (90%)
- Seed (4%)
- Series Unknown (2%)
- Pre Seed (2%)
- Angel (1%)
- Non Equity Assistance (1%)
Country Focus
- United States (96%)
- India (2%)
- Japan (1%)
- Puerto Rico (1%)
- Germany (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Software
- Therapeutics
- Manufacturing
- Pharmaceutical
- Medical Device
- Artificial Intelligence (Ai)
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.